Standout Papers
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1 (2008)
- Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)
Immediate Impact
27 by Nobel laureates 32 from Science/Nature 98 standout
Citing Papers
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
2021 Standout
Shared and Distinct Functions of Type I and Type III Interferons
2019 Standout
Works of Naomi Hunder being referenced
Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†
2010
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Naomi Hunder | 1426 | 725 | 407 | 1088 | 35 | 2.4k | |
| Daniel Molin | 1490 | 1285 | 213 | 900 | 75 | 2.4k | |
| Leonardo Flenghi | 865 | 1449 | 261 | 975 | 35 | 2.7k | |
| Joke W. Baars | 923 | 880 | 275 | 500 | 52 | 2.3k | |
| Alfred C. Feller | 1088 | 1061 | 407 | 642 | 65 | 2.8k | |
| T Radaszkiewicz | 592 | 1190 | 322 | 893 | 66 | 2.4k | |
| Ingrid Simonitsch‐Klupp | 568 | 1045 | 251 | 788 | 92 | 2.3k | |
| K Aozasa | 1498 | 874 | 477 | 481 | 71 | 2.8k | |
| Kay M. Ristow | 1615 | 1782 | 323 | 608 | 76 | 2.8k | |
| Horst Dürkop | 1187 | 1594 | 281 | 1708 | 58 | 3.9k | |
| J. Bosq | 1225 | 1309 | 246 | 558 | 70 | 2.7k |
All Works
Loading papers...